In the Women's Health Initiative, researchers observed US women aged 50 to 79 years for an average of 12 years and noted which individuals developed cancer. At the beginning of the study, the women were asked which medications they took, what they ate, and what activities they performed.
|Dr. Jean Tang|
Overall, women who used aspirin had a 21 percent lower risk of melanoma relative to non-users. Each incremental increase in duration of aspirin use (less than one year of use, one to four years of use, and five or more years of use) was associated with an 11 percent lower risk of melanoma.
Thus, women who used aspirin for five or more years had a 30 percent lower melanoma risk than women who did not use aspirin. The researchers controlled for differences in pigmentation, tanning practices, sunscreen use, and other factors that may affect skin cancer risk.
For anyone who has a high degree of risk of melanoma cancer, the simplicity of an inexpensive aspirin offers a degree of comfort in the fight against cancer.
Dr. Tang noted that the findings support the design of a clinical trial to directly test whether aspirin can be taken to prevent
For more information and insight, please review the information on NPR. For more information on melanoma, please visit my friends at Memorial Sloan Kettering Cancer Hospitall.